Cholangiocarcinoma
Conditions
Interventions
Bile duct dilatation group:None
Sponsors
The Second Hospital of Hebei Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria for patients in the cholangiocarcinoma group: (1) Patients suspected of having cholangiocarcinoma (2) Patients with a confirmed diagnosis of cholangiocarcinoma based on postoperative pathological reports (3) Patients without a history of ERCP or upper gastrointestinal surgery (4) Patients who have not used antibiotics or probiotics within 3 months (5) Patients without severe bacteremia or sepsis and without other serious comorbidities (6) Patients who did not undergo emergency ERCP within 12 hours. Inclusion criteria for patients in the benign bile duct dilation disease group: (1) Patients with benign bile duct dilation diseases (such as bile duct dilation caused by chronic pancreatitis) (2) The other criteria are the same as those for the cholangiocarcinomar group.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Metagenomic next-generation sequencing;Metabonomic analysis; | — |
Countries
China
Contacts
Public ContactTingting Yu
The Second Hospital of Hebei Medical Unciversity
Outcome results
None listed